Document is current
Any future updates will be listed below
-
Authors
Mac Aogáin, Micheál https://orcid.org/0000-0002-1726-7700
Narayana, Jayanth Kumar https://orcid.org/0000-0001-8794-9048
Tiew, Pei Yee
Ali, Nur A’tikah Binte Mohamed
Yong, Valerie Fei Lee https://orcid.org/0000-0003-4243-3659
Jaggi, Tavleen Kaur
Lim, Albert Yick Hou
Keir, Holly R. https://orcid.org/0000-0001-7197-701X
Dicker, Alison J. https://orcid.org/0000-0002-4791-3259
Thng, Kai Xian
Tsang, Akina
Ivan, Fransiskus Xaverius
Poh, Mau Ern https://orcid.org/0000-0003-0971-2795
Oriano, Martina
Aliberti, Stefano
Blasi, Francesco https://orcid.org/0000-0002-2285-9970
Low, Teck Boon
Ong, Thun How
Oliver, Brian
Giam, Yan Hui
Tee, Augustine
Koh, Mariko Siyue
Abisheganaden, John Arputhan
Tsaneva-Atanasova, Krasimira https://orcid.org/0000-0002-6294-7051
Chalmers, James D.
Chotirmall, Sanjay H. https://orcid.org/0000-0003-0417-7607
- License Information
-
More Information
Article History
Received: 30 April 2020
Accepted: 16 February 2021
First Online: 5 April 2021
Competing interests
: J.D.C. has received research grants from GlaxoSmithKline, Boehringer-Ingelheim, AstraZeneca, Gilead Sciences, Grifols and Insmed, and has received personal fees from GlaxoSmithKline, Boehringer-Ingelheim, AstraZeneca, Chiesi, Grifols, Napp, Novartis, Insmed and Zambon, all outside of the submitted work. S.A. has received personal fees from Bayer Healthcare, Grifols, AstraZeneca and Zambon, and research grants and personal fees from Chiesi, Insmed, GlaxoSmithKline, Menarini, ZetaCube Srl and Fisher & Paykel, all outside of the submitted work. F.B. has received research grants and personal fees from AstraZeneca, Bayer, Chiesi, GlaxoSmithKline, Guidotti, Grifols, Insmed, Menarini, Novartis, Pfizer and Zambon, all outside of the submitted work. All other authors have no competing interests.
